Get the Stockscreener App
13.51
5.38%
-0.81
Gh Research Plc stock is traded at $13.51, with a volume of 175.15K.
It is down -5.38% in the last 24 hours and up +3.44% over the past month.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
See More
Previous Close:
$14.32
Open:
$14.28
24h Volume:
175.15K
Relative Volume:
0.64
Market Cap:
$702.90M
Revenue:
-
Net Income/Loss:
$-41.43M
P/E Ratio:
-17.10
EPS:
-0.79
Net Cash Flow:
$-39.97M
1W Performance:
-5.34%
1M Performance:
+3.44%
6M Performance:
+18.96%
1Y Performance:
+66.26%
1-Day Range:
$13.43
$14.77
1-Week Range:
$12.50
$14.77
52-Week Range:
$6.72
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
13.51 | 888.26M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.62 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.93 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.49 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
823.27 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.13 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Jun-04-25 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-13-25 | Initiated | Guggenheim | Buy |
| Mar-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Feb-13-25 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-16-22 | Initiated | H.C. Wainwright | Buy |
| Jun-16-22 | Initiated | ROTH Capital | Buy |
View All
Gh Research Plc Stock (GHRS) Latest News
Historical volatility pattern of GH Research PLC visualizedMarket Growth Review & Free AI Powered Buy and Sell Recommendations - newser.com
Is GH Research PLC stock oversold or undervaluedPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Is GH Research PLC stock dividend yield sustainable2025 Retail Activity & Stepwise Trade Execution Plans - newser.com
Can GH Research PLC (1KA) stock deliver consistent EPS growth2025 Short Interest & Real-Time Volume Trigger Notifications - newser.com
Will breakout in GH Research PLC lead to full recovery2025 Technical Patterns & Intraday High Probability Alerts - newser.com
What’s next for GH Research PLC stock price2025 Key Highlights & High Conviction Investment Ideas - newser.com
Is GH Research PLC showing signs of accumulationJuly 2025 News Drivers & Stock Market Timing Techniques - newser.com
What data driven models say about GH Research PLC’s futureJuly 2025 Setups & Risk Managed Investment Signals - newser.com
How sustainable is GH Research PLC stock dividend payoutPrice Action & Reliable Entry Point Trade Alerts - newser.com
Real time alert setup for GH Research PLC performance2025 Technical Patterns & Risk Managed Investment Signals - newser.com
Will GH Research PLC stock benefit from green energy trends2025 Breakouts & Breakdowns & Technical Pattern Based Signals - newser.com
Will GH Research PLC stock deliver long term returnsWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com
Why GH Research PLC (1KA) stock remains stable2025 EndofYear Setup & Low Risk High Reward Ideas - newser.com
Is GH Research PLC stock a safe buy before earningsTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Why millennials buy GH Research PLC (1KA) stockM&A Rumor & Long-Term Safe Return Strategies - newser.com
GH Research (NASDAQ:GHRS) Trading Up 10.2%Here's What Happened - MarketBeat
Combining machine learning predictions for GH Research PLCJobs Report & High Accuracy Swing Entry Alerts - newser.com
Has GH Research PLC formed a bullish divergenceJuly 2025 Institutional & Verified Short-Term Plans - newser.com
Tools to assess GH Research PLC’s risk profileMarket Activity Recap & Free Community Consensus Stock Picks - newser.com
Why GH Research PLC stock is favored by pension fundsInflation Watch & Verified Technical Signals - newser.com
Published on: 2025-10-31 05:32:59 - newser.com
Is GH Research PLC stock attractive for income investorsMarket Weekly Review & Weekly Stock Performance Updates - newser.com
Order flow analysis tools used on GH Research PLCQuarterly Earnings Summary & Daily Technical Forecast Reports - newser.com
Will GH Research PLC (1KA) stock see valuation expansionTrade Volume Summary & Free Growth Oriented Trading Recommendations - newser.com
Measuring GH Research PLC’s beta against major indices2025 Trade Ideas & Smart Swing Trading Techniques - newser.com
Visual analytics tools that track GH Research PLC performanceJuly 2025 Trade Ideas & AI Based Buy and Sell Signals - newser.com
Gh Research Plc Stock (GHRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):